Eplerenone: a new aldosterone receptor antagonist--are the FDAs restrictions appropriate?
{{output}}
Eplerenone is a new aldosterone receptor antagonist that will be used in the treatment of hypertension. Like spironolactone, it is a compound that can be associated with the development of hyperkalemia. Therefore, the same prescription considerations that are ... ...